About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.36 (+3.51%)
CNTBNASDAQConnect Biopharma Holdings Ltd
Loading watchlist status…
Connect Biopharma Holdings Ltd share price
CNTB price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
CNTB price performance
-5,22%
5D
6,79%
1M
-16,31%
YTD
36,42%
1Y
CNTB price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/Aquote.marketSignals